63.02

0.68% -0.43

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $63.02, with a volume of 968.13K. It is down -0.68% in the last 24 hours and down -16.24% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$63.45

Open:

$63.7

24h Volume:

968.13K

Relative Volume:

1.27

Market Cap:

$3.17B

Revenue:

$1.36B

Net Income/Loss:

$123.81M

P/E Ratio:

26.15

EPS:

2.41

Net Cash Flow:

$20.35M

1W Performance:

+1.06%

1M Performance:

-16.24%

6M Performance:

-16.43%

1Y Performance:

-13.99%

1-Day Range:

$62.38

$64.31

1-Week Range:

$61.64

$65.14

52-Week Range:

$58.80

$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1169)

Industry

Medical Instruments & Supplies (61)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,657

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-11-07

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE Haemonetics Corp	63.02	3.17B	1.36B	123.81M	20.35M	2.41
ISRG Intuitive Surgical Inc	591.79	211.07B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	227.43	65.30B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	90.31	44.67B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	231.69	34.04B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	88.48	17.62B	3.90B	392.30M	288.10M	1.95

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform
Dec-06-24	Initiated	JP Morgan	Overweight
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-13-24	Initiated	CL King	Buy
Sep-11-24	Initiated	BofA Securities	Neutral
Sep-10-24	Initiated	BTIG Research	Buy
Jun-12-24	Upgrade	Needham	Hold → Buy
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Feb 21, 2025

Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World

Feb 21, 2025

Feb 18, 2025

(HAE)Analyzing Haemonetics's Short Interest - Benzinga

Feb 18, 2025

Feb 15, 2025

SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat

Feb 15, 2025

Feb 14, 2025

Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat

Feb 14, 2025

Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat

Feb 14, 2025

Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat

Feb 14, 2025

Feb 13, 2025

Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World

Feb 13, 2025

Feb 12, 2025

Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat

Feb 12, 2025

Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat

Feb 12, 2025

Haemonetics (NYSE:HAE) Price Target Cut to $100.00 by Analysts at JMP Securities - MarketBeat

Feb 12, 2025

Haemonetics Co. (NYSE:HAE) Receives $101.67 Consensus Target Price from Analysts - Defense World

Feb 12, 2025

Feb 11, 2025

Haemonetics (NYSE:HAE) Raised to "Buy" at StockNews.com - MarketBeat

Feb 11, 2025

Haemonetics (NYSE:HAE) Downgraded to Underperform Rating by Bank of America - MarketBeat

Feb 11, 2025

Haemonetics' (HAE) "Strong-Buy" Rating Reaffirmed at Raymond James - MarketBeat

Feb 11, 2025

Haemonetics (NYSE:HAE) Reaches New 52-Week Low After Analyst Downgrade - Defense World

Feb 11, 2025

Feb 10, 2025

Barrington Research Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat

Feb 10, 2025

Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World

Feb 10, 2025

Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James - Armenian Reporter

Feb 08, 2025

Feb 07, 2025

Haemonetics Co. (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat

Feb 07, 2025

Haemonetics (HAE) Q3 Earnings Meet Estimates - MSN

Feb 07, 2025